| __timestamp | Apellis Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 33472000 |
| Thursday, January 1, 2015 | 13730311 | 47368000 |
| Friday, January 1, 2016 | 22978599 | 66871000 |
| Sunday, January 1, 2017 | 40303878 | 50675000 |
| Monday, January 1, 2018 | 105285576 | 78821000 |
| Tuesday, January 1, 2019 | 220968770 | 91944000 |
| Wednesday, January 1, 2020 | 299921000 | 111234000 |
| Friday, January 1, 2021 | 420869000 | 207447000 |
| Saturday, January 1, 2022 | 387236000 | 267587000 |
| Sunday, January 1, 2023 | 354387000 | 303055000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Apellis Pharmaceuticals and HUTCHMED (China) Limited have been at the forefront of this race. From 2014 to 2023, Apellis Pharmaceuticals has consistently increased its R&D investment, peaking in 2021 with a staggering 420% increase from its 2014 levels. Meanwhile, HUTCHMED has shown a steady upward trend, with a notable 800% rise in R&D spending over the same period.
By 2023, Apellis's R&D expenses slightly decreased by 16% from its 2021 peak, while HUTCHMED continued its upward trajectory, closing the gap with a 13% increase from the previous year. This data highlights the dynamic nature of the pharmaceutical industry, where strategic investments in R&D can significantly impact a company's competitive edge and market position.
Research and Development Investment: Pfizer Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and HUTCHMED (China) Limited
Analyzing R&D Budgets: Zoetis Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Incyte Corporation or HUTCHMED (China) Limited: Who Invests More in Innovation?
Amneal Pharmaceuticals, Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Apellis Pharmaceuticals, Inc. vs Mesoblast Limited: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.